Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6056044 | 1.00 | GSTP1 (1.00) | GSTP1GSTM2 | |
| SCHEMBL6049336 | 0.99 | GSTP1 (1.00) | GSTP1GSTM2 | |
| SCHEMBL300204 | 0.89 | GSTP1 (0.82) | GSTP1GSTM2 | |
| SCHEMBL27142039 | 0.86 | GSTP1 (0.77) | GSTP1GSTM2 | |
| SCHEMBL6049348 | 0.84 | GSTP1 (0.74) | GSTP1GSTM2 | |
| SCHEMBL3502370 | 0.81 | GSTP1 (0.74) | GSTP1GSTM2 | |
| SCHEMBL6056085 | 0.80 | GSTP1 (0.64) | GSTP1GSTM2 | |
| SCHEMBL13906505 | 0.80 | GSTP1 (0.76) | GSTP1GSTM2 | |
| SCHEMBL13997681 | 0.77 | GSTP1 (0.66) | GSTP1GSTM2 | |
| SCHEMBL18878890 | 0.76 | GSTP1 (0.77) | GSTP1GSTM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025125504-A1 | COMBINED AGENTS WITH SYNERGISTIC EFFECTS AGAINST GLIOMAS | EBERHARD KARLS UNIVERSITAET TUEBINGEN MEDIZINISCHE FAKULTAET (DE) | 2025-06-19 | — | — | WO | claimed |
| EP-4570246-A1 | COMBINED AGENTS WITH SYNERGISTIC EFFECTS AGAINST GLIOMAS | Eberhard Karls Universität Tübingen Medizinische Fakultät (DE) | 2025-06-18 | — | — | EP | claimed |
| CN-119591587-A | EGFR dependent small molecule conjugate-1, 3, 4, preparation method and application thereof | 江苏省中国科学院植物研究所 | 2025-03-11 | — | — | CN | claimed |
| WO-2024054074-A1 | PHARMACEUTICAL COMPOSITION FOR SUPPRESSING CHEMOTHERAPY RESISTANCE IN SOLID TUMOR PATIENT, AND USE THEREOF | 재단법인 아산사회복지재단 | 2024-03-14 | — | — | WO | claimed |
| US-8796317-B2 | Use of 7-nitro-2,1,3-benzoxadiazole derivatives for anticancer therapy | Universita Degli Studi Di Roma “Tor Vergata” (IT) | 2014-08-05 | — | — | US | claimed |
| US-20100184601-A1 | Method and Means Relating to Multiple Herbicide Resistance in Plants | UNIVERSITY OF DURHAM (GB) | 2010-07-22 | — | — | US | claimed |
| EP-2190290-A2 | METHOD AND MEANS RELATING TO MULTIPLE HERBICIDE RESISTANCE IN PLANTS | University Of Durham (GB) | 2010-06-02 | — | — | EP | claimed |
| WO-2009034396-A2 | METHOD AND MEANS RELATING TO MULTIPLE HERBICIDE RESISTANCE IN PLANTS | UNIVERSITY OF DURHAM (GB) | 2009-03-19 | — | — | WO | claimed |
| US-20060247284-A1 | Use of 7-nitro-2,1,3 benzoxadiazole derivatives for anticancer therapy | UNIVERSITA DEGLI STUDI DI ROMA "TOR VERGATA" (IT) | 2006-11-02 | — | — | US | claimed |
| EP-1615638-B1 | USE OF 7-NITRO-2,1,3 BENZOXADIAZOLE DERIVATIVES FOR ANTICANCER THERAPY | UNIV ROMA (IT) | 2006-09-27 | — | — | EP | claimed |
| CN-119591587-B | EGFR dependent small molecule conjugate-1, 3, 4, preparation method and application thereof | 江苏省中国科学院植物研究所 | 2025-10-17 | — | — | CN | disclosed |
| CN-120514866-A | NBDHEX-PD-1 inhibitor combined synergistic anti-tumor pharmaceutical composition and application | 华中科技大学同济医学院附属协和医院 | 2025-08-22 | — | — | CN | disclosed |
| CN-120514866-A | NBDHEX-PD-1 inhibitor combined synergistic anti-tumor pharmaceutical composition and application | 华中科技大学同济医学院附属协和医院 | 2025-08-22 | — | — | CN | disclosed |
| WO-2025125504-A1 | COMBINED AGENTS WITH SYNERGISTIC EFFECTS AGAINST GLIOMAS | EBERHARD KARLS UNIVERSITAET TUEBINGEN MEDIZINISCHE FAKULTAET (DE) | 2025-06-19 | — | — | WO | disclosed |
| EP-4570246-A1 | COMBINED AGENTS WITH SYNERGISTIC EFFECTS AGAINST GLIOMAS | Eberhard Karls Universität Tübingen Medizinische Fakultät (DE) | 2025-06-18 | — | — | EP | disclosed |
| WO-2009034396-A2 | METHOD AND MEANS RELATING TO MULTIPLE HERBICIDE RESISTANCE IN PLANTS | UNIVERSITY OF DURHAM (GB) | 2009-03-19 | — | — | WO | disclosed |
| US-20060247284-A1 | Use of 7-nitro-2,1,3 benzoxadiazole derivatives for anticancer therapy | UNIVERSITA DEGLI STUDI DI ROMA "TOR VERGATA" (IT) | 2006-11-02 | — | — | US | disclosed |
| EP-1615638-B1 | USE OF 7-NITRO-2,1,3 BENZOXADIAZOLE DERIVATIVES FOR ANTICANCER THERAPY | UNIV ROMA (IT) | 2006-09-27 | — | — | EP | disclosed |
| EP-1615638-A1 | USE OF 7-NITRO-2,1,3 BENZOXADIAZOLE DERIVATIVES FOR ANTICANCER THERAPY | Università degli Studi di Roma " Tor Vergata" (IT) | 2006-01-18 | — | — | EP | disclosed |
| WO-2004093874-A1 | USE OF 7-NITRO-2,1,3 BENZOXADIAZOLE DERIVATIVES FOR ANTICANCER THERAPY | UNIVERSITA' DEGLI STUDI DI ROMA 'TOR VERGATA' (IT) | 2004-11-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100184601-A1 | Method and Means Relating to Multiple Herbicide Resistance in Plants | GSTO1, GSTP1, GSR | GSTP1 2/4885GSTM2 5/4885 |
| US-20060247284-A1 | Use of 7-nitro-2,1,3 benzoxadiazole derivatives for anticancer therapy | GSTK1, GSTP1, GSTM1 | GSTP1 2/4885GSTM2 5/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.